Hsiu Mei Huang
Direktor/Vorstandsmitglied bei TaiGen Biotechnology Co., Ltd.
Profil
Hsiu Mei Huang is an Independent Director at TaiGen Biotechnology Co., Ltd.
She previously served as an Independent Director at Taiwan Liposome Co., Ltd.
and TWi Pharmaceuticals, Inc. She also held positions as Managing Director at Glaxosmithkline and General Manager & Spokesman at OBI Pharma, Inc. Huang received her undergraduate degree from National Taiwan University.
Aktive Positionen von Hsiu Mei Huang
| Unternehmen | Position | Beginn |
|---|---|---|
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Hsiu Mei Huang
| Unternehmen | Position | Ende |
|---|---|---|
| Glaxosmithkline /Taiwan/ | Corporate Officer/Principal | - |
| OBI PHARMA, INC. | Vorstandsvorsitzender | - |
| TWI PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | - |
| TAIWAN LIPOSOME COMPANY, LTD. | Direktor/Vorstandsmitglied | - |
Ausbildung von Hsiu Mei Huang
| National Taiwan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OBI PHARMA, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
Taiwan Liposome Co., Ltd.
 Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
TWi Pharmaceuticals, Inc.
 TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
| Glaxosmithkline /Taiwan/ |